Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Disease

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder characterized by high LDL cholesterol and premature heart disease.
• Defects in the LDL receptor gene are a primary cause of FH.
• Identifying specific mutations is crucial for genetic diagnosis and understanding disease mechanisms.

Purpose of the Study:

• To screen Norwegian Familial Hypercholesterolemia (FH) subjects for known mutations in the LDL receptor gene.
• To determine the frequency of identified known mutations within the Norwegian FH population.
• To evaluate the utility of screening for known mutations as part of FH genetic analysis.

Main Methods:

• Screening of 75 unrelated Norwegian FH subjects for 38 known LDL receptor gene mutations.
• DNA sequencing was used to identify both known and novel mutations.
• Frequency analysis of detected mutations in a larger cohort of FH heterozygotes.

Main Results:

• Three known mutations (FH-Padova, FH-Cincinnati-2, FH-Gujerat) were identified in the study cohort.
• Gene frequencies for these mutations were determined to be 1.3%, 1.0%, and 3.0% respectively.
• A novel stop codon mutation (S541X) was also discovered in the LDL receptor gene.

Conclusions:

• Screening for known LDL receptor gene mutations is an effective strategy for FH diagnosis in Norway.
• This approach should be used alongside novel mutation screening to comprehensively understand FH molecular genetics.
• The findings contribute to the genetic landscape of FH and inform diagnostic practices.